SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

SpaceXs reported plan to use Grain Managements 800 MHz spectrum for Starlink Mobile is driving debate about whether it threatens AST SpaceMobiles carrier-partner model. Traders are split: some see a stronger competitor and worry ASTs launch delays leave it vulnerable, while others argue SpaceXs move will push mobile carriers toward AST as a partner.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs agreement to acquire nationwide low-band spectrum licenses, positioning Starlink to expand into U.S. mobile service, is driving discussion. Traders debate whether the move creates a major growth opportunity or brings costly, difficult competition with established carriers, while an approaching share unlock adds concern about potential selling pressure.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas new defense orders, including an Electronic Safe & Arm Devices award and broader order-book growth, are drawing attention. Traders are divided over why the stock remains weak despite the contract news: bulls point to defense demand and heavy short interest, while bears focus on dilution, execution and whether orders convert into revenue.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

SpaceXs agreement to acquire low-band spectrum has renewed fears that Starlink Mobile could become a direct competitor to Verizon and other U.S. carriers, weighing on telecom shares. Traders disagree on how serious the threat is: some see a major long-term challenge, while others view it as years away and are treating the selloff as a buying opportunity, citing Verizons dividend.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is selling off alongside fiber-optics and photonics peers as reports of a lower-than-previously-believed OpenAI revenue run rate weigh on sentiment around AI infrastructure spending. Traders are split between viewing the drop as a sector-wide overreaction and buying opportunity, and expecting further declines amid volatility and concerns about share dilution.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceX/Starlinks plans to build a mobile network and compete for wireless customers have put AT&T in focus, with traders debating whether the threat is meaningful or overstated given the rollouts technical and infrastructure challenges. The discussion is split between concern about long-term competition and buyers viewing telecom weakness as an opportunity, citing AT&Ts existing network, fiber business and dividend.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs reported spectrum acquisition and plans to expand Starlink into mobile service have raised concerns about stronger competition for T-Mobile and other U.S. carriers. Traders are split between fearing pressure on carrier growth and viewing satellite service as a limited, longer-term threat, with some treating the selloff as a buying opportunity.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNavs proposed lower-900 MHz spectrum item was left off the FCC meeting agenda, delaying a key regulatory catalyst and weighing on the shares. Traders are split between viewing SpaceXs spectrum activity as support for the scarcity thesis and focusing on the uncertainty around FCC approval and its timing.

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.

Alignment Healthcare Inc

Concern over updated CMS Medicare Advantage star ratings is driving discussion, with traders focused on the California HMO contracts lower rating and possible effects on future quality bonuses and rebate economics. Some view the impact as a delayed 2028 risk that Alignment can challenge or mitigate, while others see the downgrade as a reason for continued selling; no listed article directly verifies this catalyst.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RVMD is under pressure after reports that FDA review documents flagged uneven daraxonrasib responses across KRAS subtypes, raising questions about the breadth of its recently approved pancreatic-cancer therapy. Traders are debating the significance and credibility of the subgroup concerns, while some view the pullback as an overreaction or broader-market weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals that advance access to the Quanterix SIMOA technology and...

Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026

Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it introduced at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting new updates at the European Society for Spatial Biology (ESSB) September 28-October 1...

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix...

Quanterix (QTRX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's after-market session. The company's market cap stands at $4.9 million.
Quanterix (NASDAQ:QTRX) shares increased byread more...

Quanterix Q2 Earnings Call Highlights

Quanterix Names Jim Gute Chief Commercial Officer

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that seasoned healthcare executive Jim Gute has been appointed Chief Commercial Officer of the company. In this role, he will lead a re-acceleration of growth within the companys commercial...

Quanterix Releases Financial Results for the Second Quarter of 2026

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the second quarter ended June 30, 2026. We made meaningful progress in the second quarter, including strengthening our leadership team and preserving cash better than planned...

Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that senior management will participate in the Canaccord Genuity Capital Markets 46th Annual Growth Conference at the Intercontinental Hotel in Boston on August 11-12, 2026. Chief Executive Officer...

Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026

Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, August 10, 2026, at 8:30 AM ET, to discuss its second quarter 2026 financial results. Quanterix will issue a press release regarding its second...

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Quanterix Corp

TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today 

Equity

Bullish Sentiment

Buying

Holding

Selling

A.I. stocks sold off after a report that OpenAI&#39;s annualized revenue is $20 billion lower than previously reported. What are you doing right now?

Stocktwits

A.I. stocks sold off after a report that OpenAI's annualized revenue is $20 billion lower than previously reported. What are you doing right now?

Stocktwits Polls

$QTRX interesting setup here with insider buys on potential climax sell-off low - was trading below cash few days ago - thin trading but could be good for spec off 2-3s. Genomics/Bios doing well

So Generous

$QTRX Big volume yesterday, guess a large seller got taken out - question is with today's trading reaction, did a key investor finally get involved done here?

IOMASS

$QTRX This was always an Alzheimers play.  Gold standard diagnostic test.  Without a therapy, no one needs diagnosis.  Now it looks like Lily may have something that actually helps.  If they work out something effective, this could rise from the dead in six months.  (That's six months from an effective threapy emerging, not from now.) 
 
Interesting.

Feed

News

Sentiment

Earnings

Fundamentals

Info

QTRX Quanterix Corp

Fundamentals

Latest QTRX News